Atlas Trials

Butantan Institute

31 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Butantan Institute

RecordFirmDate
Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikungunya Vaccines Compared to Separate Administration in Adults Aged 18 to 59 Years. (NCT06973772)Butantan Institute2027-03-31
Phase 3b Trial To Evaluate Safety And Immune Response (Superiority) of a Two-Dose Butantan-DV Regimen And The Standard Single Dose In Dengue-Naive Children/Adolescents and Immune Response (Non-inferiority) in a Manufacturing Facility Change (DEN-06-IB) (NCT07712926)Butantan Institute2027-02-01
Butantan-DV Vaccine in Elderly Populations (DEN-04-IB) (NCT06891950)Butantan Institute2026-03-03
Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adults and Older Adults (NCT06842173)Butantan Institute2025-09-10
Immunogenicity and Safety of Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated) in Infants and Children . (NCT05779020)Butantan Institute2023-04-25
Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine (NCT05354024)Butantan Institute2023-02-28
Clinical Bridging Study Between V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) to Butantan Dengue Vaccine (Butantan - DV) in Healthy Adults 18 to 50 Years of Age in Brazil (V181 - 002) (NCT05710224)Butantan Institute2023-02-15
A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents (NCT04650399)Butantan Institute2022-02-14
Clinical Trial of the COVID-19 Vaccine (Recombinant, Inactivated) in Brazil (NCT04993209)Butantan Institute2021-07-09
Safety and Immunogenicity of the Butantan Quadrivalent Influenza Vaccine (NCT03927131)Butantan Institute2021-05-12
Active Pharmacovigilance Study of Adsorbed COVID-19 (Inactivated) Vaccine (NCT04845048)Butantan Institute2021-05-10
Clinical Trial to Assess Safety and Immunogenicity of a Synthetic Vaccine Against Streptococcus Pyogenes (NCT03998592)Butantan Institute2021-05-01
Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases (NCT04834089)Butantan Institute2021-05-01
An Effectiveness Study of the Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine (NCT04747821)Butantan Institute2021-02-07
Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil (AVISA) (NCT04355338)Butantan Institute2020-10-25
Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals (NCT04456595)Butantan Institute2020-07-21
Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of São Paulo (NCT04408014)Butantan Institute2020-06-01
Safety and Immunogenicity of the Butantan Institute Influenza Vaccine Compared to Sanofi Pasteur Influenza Vaccine (NCT03777163)Butantan Institute2019-04-22
Safety and Immunogencity of H7N9 Influenza Antigen With 2 Adjuvant Formulations in Healthy Adults in Brazil (NCT03330899)Butantan Institute2018-09-24
Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018) (NCT03392207)Butantan Institute2018-04-23

Track Butantan Institute automatically

Every clearance here is in the API, with alerts when new ones post.